What is the Impact Factor of Reviews on Recent Clinical Trials?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Reviews on Recent Clinical Trials is 1.20, ranking in quartile Q4 of Web of Science (ESCI).

Is Reviews on Recent Clinical Trials indexed in Web of Science or Scopus?

Yes, Reviews on Recent Clinical Trials is indexed in Web of Science (ESCI, Q4 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.325 (Q3) and an H-index of 39.

Who publishes Reviews on Recent Clinical Trials and what is the Article Processing Charge (APC)?

Reviews on Recent Clinical Trials is published by Bentham. The estimated Article Processing Charge (APC) is approximately $2,752 USD, subject to institutional waivers and corresponding author affiliations.

WoS ESCI Q4Scopus Q3SCImago #16,359Hybrid

Reviews on Recent Clinical Trials

Identifier (ISSN):1574-8871(Print)/1876-1038(Online)

•

Publisher:Bentham

Clarivate JCR Index Advisory: Active (ESCI)

Compare

Clarivate IF (2026)

1.2↑ +0.2

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS ESCIJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Reviews on Recent Clinical Trials

WoS Q4

Annual Impact Factor Metric

Current (2026):1.2

Scopus SJR & RankScopus Q3

0.325

#16,359

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

39 papers with at least that number of citations each

WoS: ESCIQ4

Self-Citation Rate7.1%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

52articles/year

4% Gold OA•62.86% Original Research

Aims & Scope

Reviews on Recent Clinical Trials publishes frontier reviews on recent clinical trials of major importance. The journal"s aim is to publish the highest quality review articles in the field. Topics covered include: important Phase I – IV clinical trial studies, clinical investigations at all stages of development and therapeutics. The journal is essential reading for all researchers and clinicians involved in drug therapy and clinical trials.

Topics Covered (Recognized by AI)

Medicine99.9%Internal medicine85.7%Biology82.4%Pathology69%Surgery50.1%Genetics46.7%Chemistry36.1%Psychology33.9%Biochemistry30.7%Intensive care medicine29.4%Psychiatry28.9%Disease27.5%Bioinformatics26.8%Immunology26.7%Cancer24.3%Endocrinology23.2%Clinical trial22.2%Radiology21.8%

Primary Research Areas

Pharmacology & Pharmacy

NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRESCI2026

PHARMACOLOGY & PHARMACY

Rank307/356

IndexESCI

JCIESCI2026

PHARMACOLOGY & PHARMACY

Rank307/356

IndexESCI

Category	Index	Rank	Quartile
PHARMACOLOGY & PHARMACY	JCRESCI	307/356	Q4
PHARMACOLOGY & PHARMACY	JCIESCI	307/356	Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF1.2

Articles / Year58

Total Citations2

2025

IF1

Articles / Year55

Total Citations71

2024

IF1.4

Articles / Year36

Total Citations89

2023

IF1.9

Articles / Year41

Total Citations114

2022

IF—

Articles / Year40

Total Citations198

Year	Impact Factor	Articles / Year	Total Citations
2026	1.2	58	2
2025	1	55	71
2024	1.4	36	89
2023	1.9	41	114
2022	—	40	198
2021	—	56	287
2020	—	82	794
2019	—	45	433
2018	—	54	828
2017	—	51	683
2016	—	56	406
2015	—	78	1,273

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #16,359Scopus Q3SCImago Profile

Scopus Coverage:2006-2025

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q3

0.325

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3

Citations / Doc (2 years)

1.50

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,752 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations145

3-Year Documents112

Citable Documents102

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate53.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q3

PharmacologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 7.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区PHARMACOLOGY & PHARMACY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Reviews on Recent Clinical Trials (ISSN: 1574-8871) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACY, published by Bentham in United Arab Emirates. The periodical holds a Journal Impact Factor (JIF) of 1.20, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.325 (Q3), an H-index of 39.

The journal enforces rigorous peer evaluation with an annual output of approximately 52 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,752 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.